News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
46 Results
Type
Article (2)
Company Profile (1)
Press Release (43)
Section
Business (3)
Deals (1)
Drug Development (7)
FDA (1)
News (9)
Tag
Alliances (2)
Approvals (1)
Cancer (1)
CAR-T (1)
Cell therapy (3)
Clinical research (11)
C-suite (1)
Data (7)
Events (25)
FDA (2)
Funding (1)
IPO (1)
Manufacturing (1)
NextGen: Class of 2026 (1)
Non-profit (2)
People (2)
Pharmaceutical (1)
Phase I (3)
Phase II (3)
Phase III (7)
Pipeline (2)
Regulatory (1)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (12)
2026 (3)
2025 (10)
2024 (9)
2023 (4)
2022 (8)
2021 (4)
2020 (8)
Location
California (17)
Northern California (14)
United States (17)
46 Results for "orcabio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orca Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
·
1 min read
Press Releases
Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization
January 9, 2026
·
3 min read
Press Releases
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 2026 Tandem Meetings of ASTCT® and CIBMTR®
January 22, 2026
·
5 min read
Press Releases
Orca Bio Presents New Clinical Data on its Pipeline of High-Precision Cell Therapies including Orca-Q® Without GvHD Prophylaxis and Orca-T/CAR-T Combination Therapy at the 67th ASH Annual Meeting
December 9, 2025
·
5 min read
Press Releases
Orca Bio Announces Orca-T® Phase 3 Data Published in Blood Demonstrate Significant Improvement in Survival Free from Chronic Graft versus Host Disease in Patients with Hematological Malignancies
December 16, 2025
·
7 min read
Press Releases
Orca Bio Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Orca-T® to Treat Hematological Malignancies
October 7, 2025
·
3 min read
Press Releases
Orca Bio to Present New Clinical Data on Its High-Precision Cell Therapies at the 67th American Society of Hematology Annual Meeting
November 3, 2025
·
5 min read
Press Releases
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
December 8, 2025
·
8 min read
Press Releases
Orca Bio Appoints Key Executives Including Steve Gavel as Chief Commercial Officer
June 5, 2025
·
3 min read
Press Releases
Orca Bio Announces Leadership Updates - May 12, 2025
May 13, 2025
·
4 min read
1 of 5
Next
